Nuclear lipid signaling is an established, widespread mechanism that operates in multiple cellular processes including proliferative and differentiative responses to a variety of stimuli. In this literature review with key references highlighted, we put forward the hypothesis that differential flow through various intracrine mechanisms can dictate resultant cellular actions such as mitosis, differentiation, or apoptosis.
CoccoL, MartelliAM, GilmourRS, LetcherAJ, ManzoliFA, IrvineRF. Changes in nuclear inositol phospholipids induced in intact cells by insulin-like growth factor I. Biochem Biophys Res Commun159:720–725, 1989.
2.
ManzoliL, BilliAM, RubbiniS, BavelloniA, FaenzaR, GilmourRS, RheeSG, CoccoL.Essential role for nuclear phospholipase Cβ1 in insulin-like growth factor-1 induced mitogenesis. Cancer Res57:2137–2139, 1997.
3.
MartelliAM, GilmourRS, NeriLM, ManzoliL, CorpsAN, CoccoL.Mitogen stimulated events in nuclei of Swiss 3T3 cells: Evidence for a direct link between changes of inositol lipids, protein kinase C requirement, and the onset of DNA synthesis. FEBS Lett283:243–246, 1991.
4.
CoccoL, MartelliAM, GilmourRS. Inositol lipid cycle in the nucleus. Cell Signal6:481–485, 1994.
D'SantosCS, ClarkJH, DivechaN.Phospholipid signaling in the nucleus. Biochim Biophys Acta1436:201–232, 1998.
7.
NeriLM, CapitaniS, BorgattiP, MartelliAM. Lipid signaling and cell responses at the nuclear level. Histol Histopathol14:321–335, 1998.
8.
VannLR, WoodingFB, IrvineRF, DivechaN.Metabolism and possible compartmentalization of inositol lipids in isolated rat liver nuclei. Biochem J327:569–576, 1997.
9.
MazzottiG, ZiniN, RizziE, RizzoliR, GalanziA, OgnibeneA, SantiS, MatteucciA, MartelliAM, MaraldiNM. Immunochemical detection of polyphosphotidyl inositol 4,5-bisphosphate localization sites in the nucleus. J Histochem Cytochem43:181–191, 1995.
10.
Zini MartelliAM, CoccoL, ManzoliFA, MaraldiNM. Phosphoinositidase C isoforms are specifically localized in the nuclear matrix and cytoskeleton of Swiss 3T3 cells. Exp Cell Res208:257–269, 1993.
11.
JarpeMB, LeachKL, RabenDM. Alpha-thrombin-induced nuclear sn-1,2-diacylglycerols are derived from phosphatidyl choline hydrolysis in cultured fibroblasts. Biochemistry33:526–534, 1994.
12.
D'SantosCS, ClarkeJH, IrvineRF, DivechaD.Nuclei contain two differentially regulated pools of diacylglycerol. Curr Biol9:437–440, 1999.
13.
MarignaniPA, EpandRM, SebaldtRJ. Alkyl chain dependence of diacylglycerol activation of protein kinase C in vitro. Biochem Biophys Res Commun225:469–473, 1996.
14.
WakelamMJO. Diacylglycerol: When is it an intracellular messenger?Biochim Biophys Acta1436:117–126, 1998.
15.
NeufeldEI, MajerusPW, KreugerCM, SaffitzJE. Uptake and sub-cellular distribution of [3H]arachidonic acid in murine fibrosarcoma cells measured by electron microscope autoradiography. J Cell Biol101:573–581, 1985.
16.
CapriottiAM, FurthEE, ArrasmithME, LaposataM.Arachidonate released on agonist stimulation preferentially originated from arachidonate most recently incorporated into nuclear membrane phospholipids. J Biol Chem263:10029–10034, 1988.
17.
NeitchevaT, PeevaD.Phospholipid composition, phospholipase A2 and sphingomyelinase activities in rat liver nuclear membrane and matrix. Int J Biochem Cell Biol27:995–1001, 1995.
18.
Tamiya-KoizumiK, UmekawaH, YoshidaS, IshiharaH, KojimaK.A novel phospholipase A2 associated with nuclear matrix: Stimulation of the activity and modulation of the Ca2+ dependency by polyphosphoinositides. Biochem Biophys Acta3:182–188, 1989.
19.
Sierra-HonigmannMR, BradleyJR, PoberJS. “Cytosolic” phospholipase A2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. Lab Invest74:684–695, 1996.
20.
FayardJM, TessierC, PageauxJF, LagardeM, LaugierC.Nuclear location of PLA2–1 in proliferative cells. J Cell Sci111:985–994, 1998.
21.
FreemanEJ, RuehrML, DormanRV. ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells. Am J Physiol274:282–288, 1998.
22.
LinLL, WartmanM, LinAY, KnopfJL, SethA, DavisRJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell72:269–278, 1993.
23.
KanH, RuanY, MalikKU. Involvement of mitogen-activated protein kinase and translocation of cytosolic phospholipase A2 to the nuclear envelope in acetylcholine-induced prostacyclin synthesis in rabbit coronary endothelial cells. Mol Pharmacol50:1139–1147, 1996.
24.
MoritaI, SchindlerM, RegierMK, OttoJC, HonT, DeWittDL, SmithWL. Different intracellular locations for prostaglandin endoperoxidase H synthase-1 and −2. J Biol Chem270:861–870, 1995.
25.
MarvinKW, EykholtRL, MitchellMD. Subcellular localization of prostaglandin H synthase-2 in a human amnion cell line: Implications for nuclear localized prostaglandin signaling pathways. Prostaglandins Leukot Essent Fatty Acids62:7–11, 2000.
26.
MitsuokaS, OtsuraA, NakaoK, TsutsumiT, TsurutaS, HamasakiK, ShimaM, NakataK, TamaokiT, NagatakiS.Inhibitory effect of prostaglandin δ12-PGJ2 on cell proliferation and α-fetoprotein expression in HuH-7 human hepatoma cells. Prostaglandins43:189–197, 1992.
27.
MatsumotaK, MoritaI, MurotaS.Arachidonic acid metabolism by nuclei of a retinoic acid– or vitamin D3–differentiated human leukemia cell line HL-60. Prostaglandins Leukot Essent Fatty Acids51:51–55, 1994.
FormanBM, TontonozP, ChenJ, BrunRP, EvansRM. 15-deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte differentiation factor PPAR. Cell83:803–812, 1995.
30.
VamecqJ, LatruffeN.Medical significance of peroxisome proliferator-activated receptors. Lancet354:141–148, 1999.
31.
AuwerxJ.PPARγ, the ultimate thrifty gene. Diabetologia42:1033–1049, 1999.
32.
GottlicherM, WindmarkE, LiQ, GustafssonJA. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci U S A89:4653–4657, 1992.
33.
GulickT, CresciS, CairaT, MooreDD, KellyDP. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme expression. Proc Natl Acad Sci U S A91:11012–11016, 1994.
34.
IssemannI, GreenS.Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature347:645–650, 1990.
35.
KliewerSA, ForemanBM, BlumbergB, OngES, BorgmeyerU, MangelsdorfDJ, UmesonoK, EvansRM. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A91:7355–7359, 1994.
36.
ForemanBM, TontonozP, ChenJ, BrunRP, SpiegelmanBM, EvansRM. 15-deoxy-Δ1214-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell83:803–812, 1995.
37.
TontonozP, KimJB, GravesRA, SpiegelmanBM. A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol13:4753–4759, 1993.
38.
KimJB, WrightHM, WrightM, SpiegelmanBM. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proc Natl Acad Sci U S A95:4333–4337, 1998.
39.
ManzoliL, BilliAM, GilmourRS, MartelliAM, MatteucciA, RubbiniS, WeberG, CoccoL.Phosphoinositide signaling in the nuclei of Friend cells: Tiazofurin downregulates phospholipase Cβ,. Cancer Res55:2978–2980, 1995.
40.
MatteucciA, FaenzaI, GilmourRS, ManzoliL, BilliAM, PeruzziD, BavelloniA, RheeSG, CoccoL.Nuclear but not cytoplasmic phospholipase Cβ inhibits differentiation of erythroleukemia cells. Cancer Res58:5057–5060, 1998.
41.
MarvinKW, EykholtRL, KeelanJA, SatoTA, MitchellMD. The 15-deoxy-Δ12,14-prostaglandin J2 receptor, peroxisome proliferator-activated receptor-γ (PPAR-γ) is expressed in human gestational tissues and is functinally active in JEG3 choriocarcinoma cells. Placenta21:436–440, 2000.
42.
KeelanJA, SatoTA, MarvinKW, LanderJ, GilmourRS, MitchellMD. 15-deoxy-Δ12,14-prostaglandin J2, a ligand for peroxisome proliferator-activated receptor-γ, induces apoptosis in JEG3 choriocarcinoma cells. Biochem Biophys Res Commun262:579–585, 1999.
PetrovaTV, AkamaKT, Van EldikLJ. Cyclopentenone prostaglandins suppress activation of microglia: Downregulation of inducible nitric oxide synthase by 15-deoxy-Δ12,14 -prostaglandin J2. Proc Natl Acad Sci U S A96:4668–4673, 1999.
